1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AVROBIO Inc (AVRO)

  7. AVROBIO Inc (AVRO) Financials

AVRO

AVROBIO Inc
0.9975
0.061 (6.51%)
Upgrade to Real-Time

AVROBIO Inc. (AVRO) Fundamentals
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease.
SHARE INFORMATION
Market CapUS$ 41,288,677
Shares Outstanding44,088,283
Float38,259,684
Percent Float86.78%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -2.41
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions198
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months549,893
Institutional Holdings Percent47.3%
Institutional Sold Previous 3 Months6,062,649
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months2,630,801
Insider Holdings Percent2.1
Insider Sold Previous 3 Months433,135
Insider Shares Owned934,617
TRADING INFO
52 Week HighUS$ 1.93
52 Week LowUS$ 0.56
52 Week High ChangeUS$ -33.58
21 Day Moving AverageUS$ 1.2129
21 Day Extended Moving AverageUS$ 1.1617
50 Day Moving AverageUS$ 1.2302
50 Day Extended Moving AverageUS$ 1.1694
200 Day Moving AverageUS$ 0.938941
200 Day Extended Moving AverageUS$ 1.3108
10 Day Average Volume543,423
20 Day Average Volume487,127
30 Day Average Volume556,876
50 Day Average Volume1,547,441
Alpha-0.038467
Beta1.6286
Standard Deviation0.236387
R20.146409
7 Day Price ChangeUS$ 0.0465
7 Day Percent Change5.22%
21 Day Price ChangeUS$ -0.4235
21 Day Percent Change-31.14%
30 Day Price ChangeUS$ -0.4635
30 Day Percent Change-33.11%
Month to Date Price ChangeUS$ -0.4635
Month to Date Percent Change-33.11%
Quarter to Date Price ChangeUS$ 0.2236
Quarter to Date Percent Change31.36%
180 Day Price ChangeUS$ 0.294
180 Day Percent Change45.76%
200 Day Price ChangeUS$ 0.0497
200 Day Percent Change5.6%
Year to Date Price ChangeUS$ 0.2236
Year to Date Percent Change31.36%

AVROBIO Inc. (AVRO) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.60
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio7.60
Leverage Ratio1.30
Quick Ratio7.10
Long Term Debt To Capital0.17
VALUATION MEASURES
PE Ratio6.70
Enterprise ValueUS$ -33,334,366
Price to Sales0.00
Price to Free Cash-0.40
PE High Last 5 Years-1.50
Price To Book0.60
Price To Cash Flow0.00
PE Low Last 5 Years-12.30
Price to Tangible Book0.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-68.81
Return on Equity-86.50
Return on Capital-67.74

AVROBIO Inc. (AVRO) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOGeoff Mackay
Emplyoees78
Last AuditUE
CIK0001681087
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address100 Technology Square, Sixth Floor
Building 300, Suite 201
Cambridge, MA 2139
Websitehttps://www.avrobio.com
Facsimile-
Telephone+1 617 914-8420
Emailinfo@avrobio.com
Your Recent History
NASDAQ
AVRO
AVROBIO
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230402 05:41:00